科萨娜生物科技 KRSA
$31.05 +$0.62 (+2.04%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $31.05 0.00%
开盘$29.82
昨收$30.43
当日区间$29.70 – $31.20
成交量65.6K
市值$1.41B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$18.45M
净利润-$17.36M
摊薄每股收益-$3.42
盈利能力与资产负债表
流动比率9.71
负债/资产比率150.2%
现金及投资$121.17M
总负债$917,000.00
净现金（净负债）$120.25M
资产负债表
| 项目 | 2026 Q2 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|---|
| 流动资产合计 | $121.81M | $154.60M | $10.11M |
| 一年以上应计费用 | $430,000.00 | $538,000.00 | $0.00 |
| 长期债务及融资租赁负债 | $917,000.00 | – | – |
| -长期融资租赁负债 | $917,000.00 | – | – |
| 非流动负债合计 | $176.88M | $176.08M | $9.96M |
| 其他流动负债 | $844,000.00 | – | – |
| 现金及现金等价物与短期投资 | $121.17M | $154.14M | $10.11M |
| -现金及现金等价物 | $121.17M | $154.14M | $10.11M |
| 其他流动资产 | $639,000.00 | $461,000.00 | – |
| 非流动资产合计 | $4.35M | $0.00 | $0.00 |
| -应付账款 | $462,000.00 | $176,000.00 | $68,000.00 |
| 固定资产净值 | $1.23M | – | – |
| -固定资产原值 | $1.23M | – | – |
| 其他非流动资产 | $3.12M | – | – |
| 负债合计 | $189.43M | $188.56M | $10.04M |
| 流动负债合计 | $12.55M | $12.49M | $78,000.00 |
| 应付款 | $462,000.00 | $176,000.00 | $68,000.00 |
| 一年内应计费用 | $11.05M | $11.94M | $10,000.00 |
| 短期债务及融资租赁负债 | $191,000.00 | – | – |
| -一年内到期融资租赁负债 | $191,000.00 | – | – |
| 总资产 | $126.16M | $154.60M | $10.11M |
| 留存收益 | -$66.60M | -$35.73M | -$88,000.00 |
| 资本公积 | $3.32M | $1.76M | $153,000.00 |
| -普通股 | $1,000.00 | $1,000.00 | $1,000.00 |
| 股本 | $1,000.00 | $1,000.00 | $1,000.00 |
| 股东权益 | -$63.28M | -$33.97M | $66,000.00 |
| 股东权益合计 | -$63.28M | -$33.97M | $66,000.00 |
| 可转换优先证券 | $175.54M | $175.54M | $9.96M |
利润表
| 项目 | 2026 Q2 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|---|
| 摊薄每股收益 | -$3.42 | -$7.07 | -$0.02 |
| 基本每股收益 | -$3.42 | -$7.07 | -$0.02 |
| 归属普通股股东净利润 | -$17.36M | -$35.64M | -$88,000.00 |
| 归属母公司净利润 | -$17.36M | -$35.64M | -$88,000.00 |
| 持续经营利润 | -$17.36M | -$35.64M | -$88,000.00 |
| 净利润 | -$17.36M | -$35.64M | -$88,000.00 |
| 非经营性利息收入 | $1.09M | $1.65M | $21,000.00 |
| 非经营性利息净收入（支出） | $1.09M | $1.65M | $21,000.00 |
| 营业利润 | -$18.45M | -$37.29M | -$109,000.00 |
| 研发费用 | $15.51M | $32.79M | $56,000.00 |
| -管理费用 | $2.94M | $4.51M | $53,000.00 |
| 销售及管理费用 | $2.94M | $4.51M | $53,000.00 |
| 营业费用 | $18.45M | $37.29M | $109,000.00 |
| 税前利润 | -$17.36M | -$35.64M | -$88,000.00 |
| 营业总收入 | $0.00 | $0.00 | $0.00 |
现金流量表
| 项目 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|
| 期初现金余额 | $10.11M | $0.00 |
| 持续经营经营活动现金流净额 | -$22.41M | $44,000.00 |
| 持续经营净利润 | -$35.64M | -$88,000.00 |
| 营运资金变动 | $11.63M | $78,000.00 |
| -预付资产变动 | -$461,000.00 | $0.00 |
| -应付账款及应计费用变动 | $12.09M | $78,000.00 |
| 筹资活动现金流 | $166.43M | $10.06M |
| 持续经营筹资活动现金流净额 | $166.43M | $10.06M |
| 优先股发行净额 | $165.57M | $9.96M |
| 股票期权行使所得 | $860,000.00 | $100,000.00 |
| 期末现金余额 | $154.14M | $10.11M |
| 现金净变动 | $144.03M | $10.11M |
| 自由现金流 | -$22.41M | $44,000.00 |
| 经营活动现金流 | -$22.41M | $44,000.00 |
暂无评论——快来第一个聊聊 KRSA。
登录后参与讨论。